NCT02419495 2025-06-04Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated221 enrolled
NCT06839105 2025-05-31A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced MalignanciesShanghai Junshi Bioscience Co., Ltd.Phase 1 Recruiting214 enrolled